CLERICO, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 37.899
EU - Europa 32.121
AS - Asia 8.971
SA - Sud America 1.756
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 133
OC - Oceania 20
Totale 81.102
Nazione #
US - Stati Uniti d'America 36.916
GB - Regno Unito 14.356
RU - Federazione Russa 5.891
UA - Ucraina 3.946
SG - Singapore 2.916
DE - Germania 2.372
CN - Cina 2.361
IT - Italia 2.032
BR - Brasile 1.593
HK - Hong Kong 1.537
VN - Vietnam 1.505
CA - Canada 879
SE - Svezia 865
DK - Danimarca 782
FI - Finlandia 656
PL - Polonia 570
FR - Francia 239
EU - Europa 202
IE - Irlanda 199
IN - India 111
BD - Bangladesh 82
TR - Turchia 66
ID - Indonesia 62
ZA - Sudafrica 59
MX - Messico 57
IQ - Iraq 56
AR - Argentina 53
NL - Olanda 51
KR - Corea 50
PK - Pakistan 32
JP - Giappone 30
RO - Romania 30
UZ - Uzbekistan 29
EC - Ecuador 27
ES - Italia 27
LT - Lituania 22
MA - Marocco 22
AT - Austria 21
VE - Venezuela 21
IL - Israele 18
SA - Arabia Saudita 15
AU - Australia 14
JO - Giordania 14
SK - Slovacchia (Repubblica Slovacca) 14
UY - Uruguay 14
CO - Colombia 13
TN - Tunisia 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
IR - Iran 10
JM - Giamaica 10
KE - Kenya 10
NP - Nepal 10
DZ - Algeria 8
OM - Oman 8
PE - Perù 8
BE - Belgio 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
BH - Bahrain 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
AL - Albania 5
AO - Angola 5
CH - Svizzera 5
EG - Egitto 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
RS - Serbia 5
BB - Barbados 4
BO - Bolivia 4
HR - Croazia 4
LB - Libano 4
NI - Nicaragua 4
PS - Palestinian Territory 4
TW - Taiwan 4
AM - Armenia 3
BY - Bielorussia 3
HN - Honduras 3
KW - Kuwait 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
SM - San Marino 3
SN - Senegal 3
SV - El Salvador 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
KH - Cambogia 2
LU - Lussemburgo 2
PR - Porto Rico 2
SR - Suriname 2
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 81.089
Città #
Southend 12.638
Woodbridge 5.121
Ann Arbor 4.000
Chandler 3.260
Houston 2.989
San Mateo 2.512
Dearborn 1.956
Jacksonville 1.921
Beijing 1.820
Falls Church 1.474
Hong Kong 1.459
Singapore 1.391
Fairfield 1.187
Seattle 1.049
Cambridge 947
Wilmington 835
Moscow 831
Dong Ket 828
Stevenage 761
Portsmouth 693
Ashburn 690
Boardman 658
Lawrence 610
Warsaw 560
Brooklyn 497
Pisa 469
Ottawa 458
Chicago 378
Los Angeles 247
Santa Clara 205
The Dalles 203
Montréal 195
Dublin 185
Old Bridge 185
Salt Lake City 170
São Paulo 140
San Diego 136
Buffalo 113
Beauharnois 107
Redwood City 101
Norwalk 95
Munich 86
Tampa 83
New York 73
London 68
Milan 64
Elk Grove Village 63
Rio de Janeiro 56
Rome 56
Dallas 53
Belo Horizonte 48
Montreal 40
Boston 38
Johannesburg 38
San Francisco 38
Brasília 37
Fremont 37
Kansas City 34
Washington 34
Lancaster 33
Augusta 32
Seoul 32
Chennai 31
Curitiba 31
Central District 30
Sterling 30
Simi Valley 29
Phoenix 28
Hefei 27
Porto Alegre 27
Salerno 27
Atlanta 26
Florence 26
Tashkent 26
Helsinki 25
Nuremberg 25
Tokyo 25
Dulles 24
Mountain View 24
Bologna 23
Frankfurt am Main 23
Ho Chi Minh City 23
Baghdad 22
Dhaka 22
Nanjing 21
Mexico City 20
Miami 20
Stockholm 20
Timisoara 20
Detroit 19
Kunming 19
Toronto 19
Hanoi 18
Napoli 18
Pavia 18
Turku 17
Charlotte 16
Hanover 16
Jinan 16
Ankara 15
Totale 55.983
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.497
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 613
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 297
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 293
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 285
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 260
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 243
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 232
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 229
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 214
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 214
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 214
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 211
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 209
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 204
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 203
125I-Endothelin-1 binding sites in human cardiac tissue 195
B-type natriuretic peptide secretion following scuba diving 194
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 193
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 192
Marcatori di rimodellamento e fibrosi cardiaca 192
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 191
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 191
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 185
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 185
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 184
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 184
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 184
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 184
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 183
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 182
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 182
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 181
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 181
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 180
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 179
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 179
A chromatographic method for the determination of uric acid turnover in man 178
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 178
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 178
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 178
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 176
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 175
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 175
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 175
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 174
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 174
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 174
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 172
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 172
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 171
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 170
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 170
New and emerging biomarkers of heart failure 169
BNP values in the first days of life measured with an automated immunoassay platform 169
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 169
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 168
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 167
Genomic medicine and thrombotic risk: who, when, how and why? 166
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 165
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 164
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 164
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 164
Natriuretic peptide testing in primary care patients. 163
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 163
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 163
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 163
Ultrafiltration: a rational treatment for heart failure. 162
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia. 161
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 161
A chromatographic method for the determination of uric acid turnover in man 161
Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction 161
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. 159
Cardiac Natriuretic Hormones, Neuro-Hormones, Thyroid Hormones and Cytokines in Normal Subjects and Patients with Heart Failure. 158
Plasma levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and N-terminal fragment of pro-ANP in heart failure and in controls 158
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 158
Immunoradiometric assay of serum myosin as a marker of myocardial cell damage: methodological and clinical evaluation 157
A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors 157
Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform 157
Clinical relevance of time course of BNP levels in neonates with congenital heart diseases 157
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. 156
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 156
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases 156
Comparison of two BNP immunoassays using the same antibodies and standard materials 156
Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations 155
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 155
Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure 155
Gamma-glutamyltransferase levels are associated with inflammatory activation, myocardial dysfunction and in-hospital mortality in patients with ST-elevation myocardial infarction 155
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 155
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 154
Methodological and clinical evaluation of the Liaison automated analyser for the qunatitative detrmination of 25-OH-vitamin D. 154
Determinazione dei siti di legame dell’endotelina su membrane di atrio e di ventricolo bovino: un modello per studi di legame du tessuto cardioaco umano 154
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 154
The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. 153
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: compariosn with the old method and the Access system 153
B-type plasma natriuretic hormone level in operated Fallot patients 153
Evaluation of Analytical Performance of the Siemens ADVIA TnI Ultra Immunoassay 152
A simplified method of measuring free triiodothyronine in serum by conbined equilibrium dialysis and gel Sephadex extraction 152
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 152
Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. 151
Totale 19.574
Categoria #
all - tutte 420.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 420.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.162 332 1.907 734 473 770 1.690 1.093 324 741 382 1.035 1.681
2021/20228.252 276 1.896 208 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.831 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.286
2025/20261.497 1.497 0 0 0 0 0 0 0 0 0 0 0
Totale 81.327